National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 629492

Case Details

VAERS ID: 629492 (history)  
Age: 13.0  
Gender: Female  
Location: Foreign  
Vaccinated:2015-11-05
Onset:0000-00-00
Submitted: 2016-02-18
Entered: 2016-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTP: DTP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UN / UN
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Arthralgia, Asthenia, Decreased appetite, Headache, Malaise, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1602IRL007811

Write-up: Information has been received from Sanofi Pasteur MSD (MRF: IE-1577272925-20160012270) on 15-FEB-2016. This case was received from the health authority on 15-Feb-2016. Ref IE-HPRA-2016-025874. Initial report was received by the RA on 31/Jan/2016 from a member of the public which concerns a 13 year old female patient who experienced Malaise, Arthralgia, Pyrexia, Headache and Decreased appetite following vaccination with GARDASIL. Concomitant medications: Diphtheria Tetanus and Pertussis vaccine (brand unspecified) given on 05/11/2015. Medical history/concurrent conditions: Nil. Previously a very healthy child. The patient was vaccinated with GARDASIL via IM route on 05/Nov/2015. Post vaccination; the patient became very unwell on 07/Nov/2015, presented with achy joints and high temperature on 08/Nov/2015. She felt very weak, also headache, and no appetite.. The reported indicated that the patient was in bed for 7 days and all sporting activity was curtailed for 1 month following this reaction. Corrective treatment: Analgesia and bed rest. At the time of reporting the patient had made a complete recovery. Upon internal review the vaccine DTP was considered to be suspect.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=629492


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166